APA

Claessen B. E., Beijk M. A., Legrand V., Ruzyllo W., Manari A., Varenne O., Suttorp M. J., Tijssen J. G. P., Miquel-Hebert K., Veldhof S., Henriques J. P. S., Serruys P. W. & Piek J. J. (20100304). Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial. : Circulation. Cardiovascular interventions.

Chicago

Claessen Bimmer E, Beijk Marcel A, Legrand Victor, Ruzyllo Witold, Manari Antonio, Varenne Olivier, Suttorp Maarten J, Tijssen Jan G P, Miquel-Hebert Karine, Veldhof Susan, Henriques Jose P S, Serruys Patrick W and Piek Jan J. 20100304. Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial. : Circulation. Cardiovascular interventions.

Harvard

Claessen B. E., Beijk M. A., Legrand V., Ruzyllo W., Manari A., Varenne O., Suttorp M. J., Tijssen J. G. P., Miquel-Hebert K., Veldhof S., Henriques J. P. S., Serruys P. W. and Piek J. J. (20100304). Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial. : Circulation. Cardiovascular interventions.

MLA

Claessen Bimmer E, Beijk Marcel A, Legrand Victor, Ruzyllo Witold, Manari Antonio, Varenne Olivier, Suttorp Maarten J, Tijssen Jan G P, Miquel-Hebert Karine, Veldhof Susan, Henriques Jose P S, Serruys Patrick W and Piek Jan J. Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial. : Circulation. Cardiovascular interventions. 20100304.